RT Journal Article
SR Electronic
T1 Correction: Nemvaleukin Alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004913corr1
DO 10.1136/jitc-2022-004913corr1
VO 10
IS 11
YR 2022
UL http://jitc.bmj.com/content/10/11/e004913corr1.abstract